halofuginone has been researched along with Breast Cancer in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, Y; Cheng, L; Hang, B; Hu, J; Lei, L; Sun, Y; Wang, L; Wang, S; Xia, X; Xu, Y; Zhang, G; Zhang, X | 1 |
| Bai, Y; Hang, B; Hu, J; Lei, L; Sun, Y; Wang, L; Wang, X; Xia, X; Xu, Y; Zhang, S; Zheng, Y | 1 |
| Jin, ML; Kim, YH; Lee, SJ; Park, G; Park, SY | 1 |
| Atzmon, R; Nagler, A; Peretz, T; Shimoni, A; Vlodavsky, I; Zcharia, E | 1 |
| Connolly, CM; Lawler, J; Pines, M; Yee, KO | 1 |
5 other study(ies) available for halofuginone and Breast Cancer
| Article | Year |
|---|---|
Halofuginone-induced autophagy suppresses the migration and invasion of MCF-7 cells via regulation of STMN1 and p53.
Topics: Autophagy; Breast Neoplasms; Cell Movement; Female; Humans; MCF-7 Cells; Neoplasm Invasiveness; Piperidines; Quinazolinones; Stathmin; Tumor Suppressor Protein p53 | 2018 |
miR-31 shuttled by halofuginone-induced exosomes suppresses MFC-7 cell proliferation by modulating the HDAC2/cell cycle signaling axis.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinase Inhibitor p21; Exosomes; Female; Histone Deacetylase 2; Humans; MCF-7 Cells; Medicine, Chinese Traditional; MicroRNAs; Piperidines; Quinazolinones | 2019 |
Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase-9.
Topics: Apoptosis; Breast Neoplasms; Cell Movement; Cell Proliferation; Female; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; MCF-7 Cells; NF-kappa B; Piperidines; Proto-Oncogene Proteins c-akt; Quinazolinones; Transcription Factor AP-1 | 2014 |
Inhibition of matrix metalloproteinase-2 by halofuginone is mediated by the Egr1 transcription factor.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Early Growth Response Protein 1; Female; Gene Expression; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Piperidines; Promoter Regions, Genetic; Quinazolinones; Repressor Proteins; Transcription Factors; Up-Regulation | 2012 |
Halofuginone inhibits tumor growth in the polyoma middle T antigen mouse via a thrombospondin-1 independent mechanism.
Topics: Animals; Antigens, Viral, Tumor; Antineoplastic Agents; Breast Neoplasms; Collagen Type I; Mice; Mice, Transgenic; Neovascularization, Pathologic; Piperidines; Polyomavirus; Quinazolines; Quinazolinones; Smad2 Protein; Smad3 Protein; Thrombospondin 1; Transforming Growth Factor beta; Tumor Burden | 2006 |